Search results
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 31% Today?
InvestorPlace· 5 days agoTonix Pharmaceuticals (NASDAQ:TNXP) stock is falling hard on Monday after the company’s shares...
Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 2 days agoEquities researchers at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a note issued to investors ...
What's Going On With Tonix Pharmaceuticals (TNXP) Stock? - Tonix Pharmaceuticals (NASDAQ:TNXP)
Benzinga· 5 days agoTonix Pharmaceuticals Holding Corp TNXP shares are trading lower by 29% to $2.36 during Monday’s...
SOUN Stock Alert: SoundHound AI Pays Off Debt Early
InvestorPlace· 5 days agoSoundHound AI stock is up on Monday as SOUN investors celebrate the company paying off all of its outstanding debts with cash to spare.
US Stocks Mixed; Perion Network Shares Plunge - GameStop (NYSE:GME)
Benzinga· 5 days agoU.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 50 points on Monday....
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.09% By Investing.com
Investing.com· 3 days agoU.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.09%
Dow Surges Over 300 Points; US Inflation Rate Slows In May - ThermoGenesis Holdings (NASDAQ:THMO)
Benzinga· 3 days agoU.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on...
United States shares higher at close of trade; Dow Jones Industrial Average up 0.18%
Investing.com· 5 days agoUnited States shares higher at close of trade; Dow Jones Industrial Average up 0.18%
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In...
Benzinga· 3 days agoShares of Streamline Health Solutions, Inc. STRM fell sharply during Wednesday's session after the...
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's...
Benzinga· 5 days agoShares of Skye Bioscience, Inc. SKYE fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and ...